Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation.
Authors
Discussion
Loading...
Member takes
Implication
Laboratory study reveals cyclin D1/Cdk4 inactivates retinoblastoma protein via serine 795 phosphorylation in cell models, indicating hyperphosphorylation alone does not disable growth suppression.
Key Points
- Determine the biochemical mechanisms through which G1 cyclin-dependent kinases regulate retinoblastoma protein (pRb) function and relieve cell cycle arrest.
- Assayed pRb function using an in vivo microinjection-based cell cycle arrest model alongside in vitro kinase phosphorylation assays.
- Compared phosphorylation profiles and functional inactivation of pRb by cyclin D1/Cdk4 against Cdk2 and Cdk3 paired with cyclin A or cyclin E.
- Engineered a point mutation replacing serine 795 with alanine on pRb to test the necessity of site-specific phosphorylation for inactivation.
- Cyclin D1/Cdk4 phosphorylation functionally inactivated pRb-mediated growth suppression, whereas Cdk2 and Cdk3 complexes generated slowly migrating hyperphosphorylated forms that failed to inactivate pRb.
- Cyclin D1/Cdk4 selectively and efficiently phosphorylated serine 795 independently of an intact LXCXE motif, a site not targeted by Cdk2 or Cdk3.
- Substitution of serine 795 with alanine completely blocked Cdk4-mediated pRb inactivation in the microinjection assay, demonstrating that site-specific modification rather than general hyperphosphorylation drives inactivation.
Cite This Study
Connell‐Crowley et al. (1997) studied this question.